Streetbeat News

Stock Prices

BTAI

TSHA

ZYNE

Several healthcare stocks experienced significant movement in Monday's pre-market session. Zynerba Pharmaceuticals, Taysha Gene Therapies, Virios Therapeutics, Nemaura Medical, Trxade Health, and Mainz Biomed saw gains, while BioXcel Therapeutics, Science 37 Hldgs, PHAXIAM Therapeutics, Fortrea Holdings, NovaBay Pharmaceuticals, and Valneva experienced losses. Q2 earnings reports were recently released for several of these companies.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 1:06 pm

FRGT

NKLA

PTRA

WLGS

In Monday's pre-market session, 12 industrial stocks showed significant movement. Freight Technologies, Proterra, Recruiter.Com Group, Broadwind, Applied UV, and Markforged Holding were the gainers, with increases ranging from 8.49% to 30.4%. On the other hand, WANG & LEE Group, Nikola, Sunworks, Gaucho Group Holdings, Singularity Future Tech, and Advent Technologies Hldgs saw decreases ranging from 5.08% to 18.9%.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 1:06 pm

AIXI

ASNS

BLIN

IZM

MAPS

MIGI

MIMO

MVLA

NEON

RSSS

STIX

ZFOX

In Monday's pre-market session, several information technology stocks showed significant movement. Actelis Networks, Mawson Infra Gr, Neonode, WM Tech, Movella Holdings, and Research Solutions were among the gainers, with increases ranging from 5.09% to 26.4%. On the other hand, Airspan Networks Hldgs, Bridgeline Digital, XIAO-I, ZeroFox Holdings, ICZOOM Group, and Semantix were among the losers, with decreases ranging from 7.52% to 18.9%.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 1:06 pm

BYDDY

RIVN

TSLA

XPEV

Legacy automakers Ford (F) and General Motors (GM) are facing setbacks in their EV production, with Ford postponing the launch of its all-electric Ford Explorer and GM experiencing issues with its Ultium battery production. Meanwhile, Tesla (TSLA) has cut prices in China, intensifying competition. Rivian (RIVN) beat Q2 estimates and raised 2023 production guidance. The EV market in China also saw a slump in stocks of BYD (BYDDY), Li Auto (LI), and Xpeng (XPEV) following Tesla's price cut.

Portfolio Pulse from Upwallstreet

August 14, 2023 | 1:05 pm

COIN

Coinbase Global, Inc. (NASDAQ:COIN) has expanded its operations in Canada through a partnership with Peoples Trust Company. This move will increase Coinbase's international footprint and provide its Canadian users with access to Interac e-Transfers for secure money transfers. The partnership is expected to make cryptocurrencies more accessible to millions of Canadians. COIN shares are trading lower by 0.42% premarket to $80.93.

Portfolio Pulse from Nabaparna Bhattacharya

August 14, 2023 | 1:04 pm

BAH

Booz Allen Hamilton Holding Corporation (NYSE:BAH) has secured a follow-on production other transaction authority (OTA) agreement for at-scale deployment of Thunderdome, the Defense Information Systems Agency's (DISA) zero trust network access and application security architecture. The financial terms were not disclosed. The award follows Booz Allen's successful delivery of the Thunderdome prototype earlier this year.

Portfolio Pulse from Shivani Kumaresan

August 14, 2023 | 1:03 pm

IONQ

IonQ, Inc. reported Q2 revenue of $5.5 million, a 111% YoY increase, beating the consensus estimate of $4.35 million. However, the company reported a quarterly loss of 22 cents per share, missing analyst estimates for a loss of 13 cents per share. IonQ raised its full-year revenue outlook to $18.9 million to $19.3 million. Following the earnings announcement, Goldman Sachs, Benchmark, and Morgan Stanley increased their price targets on IonQ.

Portfolio Pulse from Lisa Levin

August 14, 2023 | 1:02 pm

LYFT

Lyft (NASDAQ:LYFT) has received mixed analyst ratings in the last quarter, with 1 bullish, 1 somewhat bullish, and 11 indifferent ratings. The average 12-month price target for Lyft is $11.98, a 27.87% decrease from the previous average of $16.61.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 1:00 pm

YMAB

In the last quarter, Y-mAbs Therapeutics (NASDAQ:YMAB) received 3 bullish ratings and 1 somewhat bearish rating from analysts. The company's average 12-month price target is $14.75, an increase of 5.36% from the previous average of $14.00.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 1:00 pm

BBIO

BridgeBio Pharma (NASDAQ:BBIO) has received positive analyst ratings in the last quarter, with an average price target of $47.25, indicating an upside from the current price of $31.07. The average price target has increased by 43.18% over the past month.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 1:00 pm